Zhaoke Ophthalmology

IPO

Public · Hong Kong, Hong Kong · Founded 2014 · $145.0M raised

Headquarters
Hong Kong
Employees
51–200
Founded
2014
Business Model
B2B
Website
zkoph.com
Total Funding
$145.0M
Last Round
$145.0M Series AOct 2020
Rounds
2
Type
Public

About

Zhaoke Ophthalmology (HKEX: 6622) is an ophthalmic pharmaceutical company founded in 2017 that researches, manufactures, and commercializes therapies for major eye diseases. Its portfolio of innovative and generic candidates covers six major indications affecting both the front and back of the eye. Many products are made at a fully operational manufacturing facility in Nansha, Guangzhou, while the company is listed in Hong Kong and focuses on bringing treatments to market to improve vision health. Through partnerships with domestic and international pharmaceutical companies, Zhaoke aims to become a global leader in ophthalmology.

Summary

Zhaoke Ophthalmology is a Biotech company based in Hong Kong, Hong Kong, founded in 2014. It has raised $145.0M in total across 2 rounds, most recently a $145.0M Series A round in Oct 2020. Investors include GIC, Hillhouse Capital and TPG (Growth/Rise).

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOApr 2021
$267.0M

Sign up to see all 3 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zhaoke Ophthalmology on Indexed.vc
<a href="https://indexed.vc/companies/zhaoke-ophthalmology"><img src="https://indexed.vc/api/badge/company/zhaoke-ophthalmology" alt="Zhaoke Ophthalmology on Indexed.vc" width="260" height="76" /></a>